Humoral immune response for early diagnosis of breast carcinoma [1]

Annals of Oncology

Volumn 13, Issue 3, 2002, Pages 483-

  Pupa, S M ^a   Forti, S ^a   Balsari, A ^a   Menard S ^a,b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN; TUMOR MARKER; CANCER ANTIBODY;

BREAST CARCINOMA; CANCER CELL CULTURE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; LETTER; PRIORITY JOURNAL; SERODIAGNOSIS; SEROLOGY; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; BREAST TUMOR; COMPARATIVE STUDY; FEMALE; GENE LIBRARY; IMMUNOLOGY;

ANTIBODIES, NEOPLASM; ANTIBODY FORMATION; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; COMPARATIVE STUDY; FEMALE; GENE LIBRARY; HUMAN; HUMANS;

EID: 0036307605     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf111     Document Type: Letter

References (2)

1. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on 17 May 1996 by the American Society of Clinical Oncology
2. New paths in human cancer serology